Showing results (1291-1300 of 1,406) with videos related to
Sort By:
Pageof 141
International Journal of Clinical and Experimental Pathology|October 23, 2014
Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, ChinaJian Ming Hu, Qi Sun, Ling Li, et al.Diabetes & Metabolic Syndrome|August 24, 2025
The association between clock gene polymorphisms and type 2 diabetes: A systematic review and meta-analysisDivya Joshi, Marie Pigeyre, Muhammad Usman Ali, et al.Journal of Translational Medicine|November 29, 2024
Diagnostic potential of salivary microbiota in persistent pulmonary nodules: identifying biomarkers and functional pathways using 16S rRNA sequencing and machine learningXiao Zeng, Qiong Ma, Chun-Xia Huang, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 17, 2024
Association of cardiovascular health metrics with all-cause and cardiovascular disease mortality in chronic kidney disease: A cohort studyShanshan Zhang, Qingping Xue, Di Li, et al.The Journal of Clinical Endocrinology and Metabolism|May 31, 2022
Serum Fetuin-A and Risk of Gestational Diabetes Mellitus: An Observational Study and Mendelian Randomization AnalysisPing Wu, Yi Wang, Yi Ye, et al.Nature Communications|May 11, 2017
TNFα drives mitochondrial stress in POMC neurons in obesityChun-Xia Yi, Marc Walter, Yuanqing Gao, et al.Carcinogenesis|December 3, 2020
Distribution and prognostic impact of M1 macrophage on esophageal squamous cell carcinomaChen Hao Jiang, Wei Hua Liang, Fan Ping Li, et al.The Journal of Clinical Endocrinology and Metabolism|August 28, 2021
A Prospective Study of Early-pregnancy Thyroid Markers, Lipid Species, and Risk of Gestational Diabetes MellitusYi Wang, Fengjiang Sun, Ping Wu, et al.Journal of Translational Medicine|May 19, 2016
PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinomaXiao-Bin Cui, Shu-Mao Zhang, Yue-Xun Xu, et al.Bioorganic Chemistry|June 3, 2025
A natural flavagline derivative A2073 inhibits the proliferation of erythroleukemia cells by targeting the MAPK, PI3K, NF-κB, and cell cycle pathwaysMan Zhou, Chun-Mao Yuan, Zhi-Xu He, et al.Pageof 141